文献速递冠心病心力衰竭与心肌病

COVID-19住院期间急性心脏事件的发生率与结局

Acute Cardiac Events During COVID-19-Associated Hospitalizations.
PubMed 文献 · J Am Coll Cardiol · 2023-01-01

基于美国14州99县COVID-19住院成人概率样本的图表抽象研究,2021年1月至11月共8460例,11.4%发生急性心脏事件,有基础心脏病者达23.4%。急性心脏事件与ICU入住(aRR 1.9)和院内死亡(aRR 1.7)风险升高相关。

要点

  • COVID-19住院成人中11.4%发生急性心脏事件,有基础心脏病者升至23.4%。
  • 急性缺血性心脏病(5.5%)和急性心衰(5.4%)最常见,心肌炎/心包炎仅0.3%。
  • 发生急性心脏事件者ICU入住风险aRR 1.9、院内死亡风险aRR 1.7。

核心结论

  • COVID-19住院期间急性心脏事件常见,尤其有基础心脏病者,并与重症结局相关。
  • 高危患者住院期间可能受益于更密集的临床评估与监测。

研究设计与样本

  • 2021年1月至11月对美国14州99县COVID-19住院成人概率样本进行病历抽象。
  • 共纳入8460例实验室确诊SARS-CoV-2感染的住院成人。
  • 急性心脏事件通过ICD-10-CM编码识别,按基础心脏病史分层分析。

主要发现

  • 8460例中11.4%(95%CI 10.1%-12.9%)发生急性心脏事件。
  • 有基础心脏病者发生率为23.4%(95%CI 20.7%-26.3%),无基础心脏病者为6.2%(95%CI 5.1%-7.6%)。
  • 急性缺血性心脏病5.5%(95%CI 4.5%-6.5%),急性心衰5.4%(95%CI 4.4%-6.6%),急性心肌炎或心包炎0.3%(95%CI 0.1%-0.5%)。
  • 发生≥1次急性心脏事件者ICU入住aRR 1.9(95%CI 1.8-2.1),院内死亡aRR 1.7(95%CI 1.3-2.1)。

临床怎么用

  • 对有基础心脏病的COVID-19住院患者应加强心脏事件监测与评估。
  • 发生急性心脏事件者需警惕ICU入住和死亡风险升高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COVID-19 is associated with cardiac complications. OBJECTIVES: The purpose of this study was to estimate the prevalence, risk factors, and outcomes associated with acute cardiac events during COVID-19-associated hospitalizations among adults. METHODS: During January 2021 to November 2021, medical chart abstraction was conducted on a probability sample of adults hospitalized with laboratory-confirmed SARS-CoV-2 infection identified from 99 U.S. counties in 14 U.S. states in the COVID-19-Associated Hospitalization Surveillance Network. We calculated the prevalence of acute cardiac events (identified by International Classification of Diseases-10th Revision-Clinical Modification codes) by history of underlying cardiac disease and examined associated risk factors and disease outcomes. RESULTS: Among 8,460 adults, 11.4% (95% CI: 10.1%-12.9%) experienced an acute cardiac event during a COVID-19-associated hospitalization. Prevalence was higher among adults who had underlying cardiac disease (23.4%; 95% CI: 20.7%-26.3%) compared with those who did not (6.2%; 95% CI: 5.1%-7.6%). Acute ischemic heart disease (5.5%; 95% CI: 4.5%-6.5%) and acute heart failure (5.4%; 95% CI: 4.4%-6.6%) were the most prevalent events; 0.3% (95% CI: 0.1%-0.5%) experienced acute myocarditis or pericarditis. Risk factors varied by underlying cardiac disease status. Patients with ≥1 acute cardiac event had greater risk of intensive care unit admission (adjusted risk ratio: 1.9; 95% CI: 1.8-2.1) and in-hospital death (adjusted risk ratio: 1.7; 95% CI: 1.3-2.1) compared with those who did not. CONCLUSIONS: Acute cardiac events were common during COVID-19-associated hospitalizations, particularly among patients with underlying cardiac disease, and are associated with severe disease outcomes. Persons at greater risk for experiencing acute cardiac events during COVID-19-associated hospitalizations might benefit from more intensive clinical evaluation and monitoring during hospitalization.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Woodruff RC, Garg S, George MG, et al. Acute Cardiac Events During COVID-19-Associated Hospitalizations. J Am Coll Cardiol. 2023. PMID: 36754516. doi:10.1016/j.jacc.2022.11.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。